CXCL1 can promote the migration and invasiveness of breast cancer by activating the transcription of SOX4 via the NF-κB pathway, resulting in the subsequent epithelial-mesenchymal transition (EMT) process [6]. Here, NFKB1 is linked to breast cancer.